Results 71 to 80 of about 17,265 (196)

Biliary Abnormality on Imaging During Lenvatinib Plus Hepatic Arterial Infusion Chemotherapy With Cisplatin for Hepatocellular Carcinoma: A Pilot Descriptive Study

open access: yesHepatology Research, EarlyView.
ABSTRACT Aim To evaluate the frequency, imaging characteristics, associated factors, and clinical significance of biliary abnormalities on imaging in patients receiving lenvatinib (LEN) plus cisplatin hepatic arterial infusion chemotherapy (HAIC) for hepatocellular carcinoma (HCC).
Hirohito Osanai   +10 more
wiley   +1 more source

A concise review of updated global guidelines for the management of hepatocellular carcinoma: 2017-2024 [PDF]

open access: yesJournal of Liver Cancer
Many guidelines for hepatocellular carcinoma (HCC) have been published and are regularly updated worldwide. HCC management involves a broad range of treatment options and requires multidisciplinary care, resulting in significant heterogeneity in ...
Hyunjae Shin, Su Jong Yu
doaj   +1 more source

Rapid Intrasegmental Progression After Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma: Incidence, Imaging Features, and Clinical Outcomes

open access: yesHepatology Research, EarlyView.
ABSTRACT Aim Radiofrequency ablation (RFA) is curative therapy for early‐stage hepatocellular carcinoma (HCC), but a rare subset of patients develop aggressive intrasegmental recurrence shortly after complete ablation. We characterized the incidence, risk factors, and absolute risk.
Takuma Kaneko   +8 more
wiley   +1 more source

Atezolizumab Plus Bevacizumab Treatment for Patients With Hepatocellular Carcinoma in the Barcelona Clinic Liver Cancer B2 Stage

open access: yesJournal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background and Aim The optimal treatment strategy for patients with intermediate‐stage hepatocellular carcinoma beyond the up‐to‐seven criteria (Barcelona Clinic Liver Cancer B2) remains uncertain. Although transarterial chemoembolization has long been the standard of care, its efficacy is limited in this subgroup, and systemic therapies have ...
Keishi Ouchi   +22 more
wiley   +1 more source

Staged caval occlusion enabling en bloc right divisional hepatectomy in two dogs with hepatocellular carcinoma

open access: yesVeterinary Surgery, EarlyView.
Abstract Objective To describe staged pre‐renal caudal vena cava (CVC) occlusion before en bloc right divisional hepatectomy with segmental caval resection in two dogs with right divisional hepatocellular carcinoma (HCC) involving the CVC. Animals Two client‐owned, 11‐year‐old neutered male dogs (Siberian Husky and Shih Tzu).
Kumiko Ishigaki, Kazushi Asano
wiley   +1 more source

Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma

open access: yesJournal of Translational Medicine
Abstract Background Hepatocellular carcinoma (HCC) is a common malignant tumor, and glutamine is vital for tumor cells. The role of glutamine transporter SLC1A5 in tumor progression and transarterial chemoembolization (TACE) efficacy is under study.
Guixiong Zhang   +5 more
openaire   +3 more sources

Missed Diagnosis in Alcohol‐Related Hepatocellular Carcinoma: A Call for Alcohol Consumption and Liver Disease Early Detection

open access: yesLiver International, Volume 46, Issue 11, November 2026.
ABSTRACT Alcohol‐related hepatocellular carcinoma is an increasingly prevalent consequence of alcohol use and the often‐silent progression of alcohol‐related liver disease. A substantial proportion of patients with alcohol‐related hepatocellular carcinoma are diagnosed at an advanced stage, frequently because underlying liver disease has not been ...
Victoria Mignot   +3 more
wiley   +1 more source

Dynamic Images for Prediction of Therapeutic Efficacy of Hepatocellular Carcinoma Treated with Transcatheter Oily Chemoembolization

open access: yesJournal of the Korean Radiological Society, 2000
Purpose: To predict the therapeutic efficacy of transcatheter oily chemoembolization(TOCE) in the treatment Materials and Methods: We reviewed the findings of 24 dynamic CT or MR scans examined for the purpose of diagnosis before TOCE, and follow-up CT scans obtained after this procedure.
Tae Yong Moon   +3 more
openaire   +1 more source

Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia

open access: yesAmerican Journal of Hematology, Volume 101, Issue 10, Page 2571-2580, October 2026.
ABSTRACT Chronic liver disease (CLD)‐related thrombocytopenia can limit the feasibility of invasive procedures. Recombinant human thrombopoietin (rhTPO) has demonstrated a favorable safety profile without hepatotoxicity. We evaluated the efficacy and safety of rhTPO in patients with CLD‐related thrombocytopenia who were undergoing elective invasive ...
Yifan Han   +45 more
wiley   +1 more source

Home - About - Disclaimer - Privacy